AKT1 and breast neoplasm: The scenario is further complicated by the expression of all three Akt isoforms in cells with a triple‐negative phenotype, with dissimilar effects on the metastatic process (Dillon et al., 2009; Grottke et al., 2016; Riggio et al., 2017), raising the problem of the identification of isoform‐specific inhibitors to be selectively used in the different breast tumor subtypes.